These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1703920)

  • 1. Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine.
    Taniguchi K; Tsujibayashi T; Itoh H
    Cardiology; 1990; 77 Suppl 5():49-56. PubMed ID: 1703920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
    Itoh H; Taniguchi K; Tsujibayashi T; Koike A; Sato Y; Nakamura S
    Cardiology; 1992; 80(5-6):356-66. PubMed ID: 1451123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
    Wehling M; Zimmermann J; Theisen K
    Cardiology; 1990; 77 Suppl 5():81-8. PubMed ID: 2279257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
    López-Sendón J
    Cardiology; 1990; 77 Suppl 5():9-21. PubMed ID: 1980634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ibopamine plus prazosin in congestive heart failure.
    Naidoo DP; Rocke A; Mitha AS
    S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
    Lieverse AG; van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Reitsma WD; Lie KI; Girbes AR
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study.
    Kleber FX; Thyroff-Friesinger U
    Cardiology; 1990; 77 Suppl 5():67-74. PubMed ID: 2279255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
    Caponnetto S; Terrachini V; Canale C; Bruzzone F; Masperone MA; Pastorino L; Licciardello L; Marchetti GV
    Cardiology; 1990; 77 Suppl 5():43-8. PubMed ID: 1980633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic evaluation of ibopamine in severe congestive heart failure.
    Reffo GC; Turrin M; Gabellini A; Forattini C
    Eur J Clin Pharmacol; 1984; 26(1):19-22. PubMed ID: 6714289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.